Frank Rimerman Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$219K Sell
2,294
-763
-25% -$73.2K 0.01% 581
2026
Q1
$317K Buy
+3,057
New +$347K 0.02% 483
2025
Q4
Sell
-2,500
Closed -$308K 608
2025
Q3
$308K Buy
+2,500
New +$310K 0.02% 481
2025
Q2
Sell
-1,571
Closed -$231K 569
2025
Q1
$231K Buy
1,571
+150
+11% +$22.9K 0.02% 469
2024
Q4
$231K Buy
1,421
+156
+12% +$25.5K 0.02% 469
2024
Q3
$206K Buy
+1,265
New +$187K 0.01% 507

Other funds holding CLX

Frank Rimerman Advisors's CLX Position: Q2 2026 in Review

Frank Rimerman Advisors reduced its Clorox (CLX) stake by 25% in Q2 2026, selling an estimated $73.2K and leaving 2,294 shares worth $219K. The position accounts for 0.01% of the portfolio, ranked #581.

Frank Rimerman Advisors first reported a position in CLX in Q3 2024 and has held it in 6 quarters since. The position peaked at $317K in Q1 2026. 1,046 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Frank Rimerman Advisors held 2,294 shares of Clorox worth $219K as of Q2 2026.
  • Frank Rimerman Advisors sold 763 Clorox shares in Q2 2026, an estimated $73.2K.
  • Clorox made up 0.01% of Frank Rimerman Advisors's portfolio in Q2 2026, its #581 holding.
  • Frank Rimerman Advisors first reported a position in Clorox in Q3 2024 and has held it in 6 quarters since.
  • Frank Rimerman Advisors's Clorox position peaked at $317K in Q1 2026.
  • 1,046 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Frank Rimerman Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.